Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Glaxo Wellcome anesthetic receives European clearance

Oct. 25, 1996

Novel antimigraine agent launched in the U.K.

Oct. 25, 1996

Antimigraine agents with affinity for 5-HT receptors reported by Pierre Fabre

Oct. 25, 1996

Anesta's Actiq on schedule for launch

Oct. 25, 1996

Neurex broadens clinical program for SNX-111

Oct. 25, 1996

Steroid does not adequately improve symptoms of chronic fatigue syndrome

Oct. 25, 1996

Efficacy of Ampligen demonstrated in chronic fatigue syndrome

Oct. 25, 1996

Clinical trials with Bradycor suspended pending clarification of anomalous animal findings

Oct. 25, 1996

NS-1201 available for licensing

Oct. 25, 1996

Daiichi reports calmodulin inhibitors

Oct. 25, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...